Iovance Biotherapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Rok finansowy 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 164
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 13699.0%
Marża brutto 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -2686.1% 24.4%
EBIT (mln) -0 -0 -1 -21 -8 -23 -12 -28 -54 -93 -128 -207 -262 -343 -399 -461 -395
EBIT Δ r/r 0.0% -72.4% 5070.0% 2502.2% -61.7% 178.4% -46.8% 131.4% 92.5% 73.2% 38.1% 61.3% 26.6% 30.8% 16.4% 15.5% -14.2%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -38735.0% -240.9%
Koszty finansowe (mln) 0 0 0 0 2 0 0 0 0 0 0 0 0 0 3 0 0
EBITDA (mln) -0 -0 0 -17 -10 -23 -12 -28 -54 -93 -128 -207 -261 -343 -399 -427 -395
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -35948.9% -240.9%
Podatek (mln) 0 0 1 5 2 0 0 -1 -1 -1 5 -10 -2 -14 -6 -3 -3
Zysk Netto (mln) -0 -0 -2 -26 -3 -25 -12 -28 -53 -92 -124 -187 -257 -328 -390 -444 -372
Zysk netto Δ r/r 0.0% -72.4% 10095.2% 1497.9% -87.1% 667.4% -52.6% 129.8% 91.2% 74.1% 34.2% 51.4% 37.5% 27.4% 18.9% 13.9% -16.2%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -37345.4% -226.8%
EPS -0.0471 -0.0414 -2.46 -33.84 -4.14 -2.6 -0.48 -0.62 -0.96 -1.41 -1.27 -1.5 -1.86 -2.14 -2.45 -1.89 -1.28
EPS (rozwodnione) -0.0471 -0.0414 -2.46 -33.84 -4.14 -2.6 -0.48 -0.62 -0.96 -1.41 -1.27 -1.5 -1.86 -2.14 -2.45 -1.89 -1.28
Ilośc akcji (mln) 1 0 1 1 1 10 25 44 55 65 97 124 138 153 159 235 290
Ważona ilośc akcji (mln) 1 0 1 1 1 10 25 44 55 65 97 124 138 153 159 235 290
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD